1. Home
  2. Blog
  3. Neuroimmunology Drug Development (NIDD) 2019

Neuroimmunology Drug Development (NIDD) 2019

Neuroimmunology Drug Development (NIDD) 2019


Find out about our quality cells and bespoke services at our booth or our workshop

We would be delighted to meet you
Make sure you stop by:

✓ Our Booth
✓ Our Presentation (find out more)

Immune response and as indicators of various inflammatory diseases, monocytes and macrophages are vital cells to study for biomedical researchers. Further understanding the behaviours of these cells will not only help to elucidate immunological mechanisms but potentially uncover new compounds to facilitate disease diagnoses.

Below we share the remarkable journey of a monocyte to macrophage as an essential component of the immune response, and explore how you can successfully use monocytes and macrophages in your research.

Presented by Axol Bioscience

“Molecular & functional characterisation of iPSC-derived Microglia: developing tools to model neurodegeneration”

Wednesday April 17, 2019
16:30 – 17:00
Martha’s Vineyard Room


Presentation Overview

Daniel Rock, Microglia Application Specialist at Axol Bioscience, will cover different areas, such as:

  • Developing a scalable and reproducible generation of physiologically-relevant microglia
  • Validation of robust, disease-relevant assays
  • Building a translatable neurodegeneration model: longitudinal monitoring of healthy and patient donor iPSC co-cultures
  • Assessing the contribution of astrocytes and microglia to the neuroinflammatory microenvironment
Axol Bioscience launch human iPSC-derived Microglia
Major success for MESO-BRAIN partners will lead to breakthrough technology for developing new brain models